Entop Spray 5 mg, 50 mg NASAL SPRAY
PDF Leaflet Revision Date: 22 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Topical anaesthesia and vasoconstriction for nasal and pharyngeal procedures.
Dosage (summary)
Adults and children over 12 years: 5 sprays per nostril or throat.
Onset of Action / Duration
Onset: Rapid, Duration: 1 hour
Special Populations
- Elderly patients
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- MAOIs
- Antihypertensives
- Digoxin
- Propranolol
Contraindications
- Hypersensitivity to lidocaine or phenylephrine
- Pregnancy and breastfeeding
- Hypovolaemia
- Hypertension
- Acute ischaemic heart disease
- Complete heart block
- Thyrotoxicosis
- Glaucoma
- Urinary retention
- Children under 12 years
Common side effects
- Transient bitter taste
- Palpitations
- Dizziness
- Nausea
- Vomiting
Counselling Points
- Avoid food/drink for 2 hours post-application
- Use caution in patients with cardiovascular issues
- Monitor for signs of systemic toxicity
Serious warnings
- Caution in cardiovascular disease
- Risk of aspiration after use
- May cause bronchospasm in asthmatics
Important Disclaimer
The Entop Spray 5 mg, 50 mg NASAL SPRAY professional information leaflet below is the property of Medfour Healthcare Cc and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
